Market Analysis

June 2014

Facial Injectables | China | 2014 | Market Analysis

Introduction:

The Chinese market for facial injectables will grow quickly over the forecast period due to the market's underpenetrated nature (compared to the US and European markets), and also because of the country's improving economy.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in China, with market projections 10 years into the future.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   The Chinese facial injectable market is characterized by large regional disparities.

Where are the fastest-growing regional markets?

What are the major Chinese cities that contribute to procedure growth?

  *   The Chinese HA filler market is expected to experience quicker growth in comparison to the BTX market.

Is this trend true in all Chinese regions covered in this report?

What factors are driving the faster growth of the HA filler segment?

  *   The Chinese facial injectable competitive landscape consists of both large international companies as well as domestic manufacturers.

What types of strategies are these two types of competitors employing to gain market share?

What factors will contribute to the success of competitors in the Chinese facial injectable market?

Which companies are the largest competitors in each of the facial injectables market in China?

Scope:

Geographies Covered: Millennium Research Group's analysis uses the following breakdown of regions in China:

Country

China

Region

PLMs

Province*

Beijing

Shanghai

Tianjin

East Coast

Province*

Fujian

Guangdong

Jiangsu

Shandong

Zhejiang

Central

Province*

Anhui

Hebei

Henan

Hubei

Hunan

Jiangxi

Shanxi

Other Regions

Region*

North

Province*

Inner Mongolia

Ningxia

Shaanxi

Northeast

Province*

Heilongjiang

Jilin

Liaoning

South

Province*

Chongqing

Guangxi

Guizhou

Hainan

Sichuan

Yunnan

West

Province*

Gansu

Qinghai

Tibet

Xinjiang

Notes: *Market metrics for this breakout are not shown quantitatively.

Procedures and Products Covered: Millennium Research Group's analysis uses the following breakdown of procedures and products:

Product Type

BTX

Dermal Fillers

Material

HA

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group use its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Susan Weng, M. Sc.

Contributors
Karen Gierszewski
Alvaro Naranjo
Veronica Ross
Kathleen Zorzella



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • Aesthetic Factors
  • Allergan
  • Anika Therapeutics
  • Beijing Aimeike
  • Beijing Mengborun Biotechnology
  • Bloomage BioTechnology
  • Clarion Medical
  • Contura
  • Fibrocell Science
  • Galderma
  • Hafod Bioscience
  • Ipsen
  • Kaylight
  • Laboratoires TEOXANE
  • LG Life Sciences
  • LIBP
  • Medicis
  • Medytox
  • Merz Pharma
  • SciVision Biotech
  • Shanghai Haohai Biological Technology
  • TICEBA
  • US WorldMeds
  • Valeant Pharmaceuticals International
Decision Resources Group brands include: